NEW YORK, Jan. 13-Orchid Biosciences has received a delisting warning notice from Nasdaq, the company said today.
Orchid's stock has traded below $1.00 since Sept. 3, which means it is in violation of the rules for continued listing on the exchange.
Orchid plans to request a hearing regarding the decision, and its stock will continue to be traded pending the outcome of that hearing.
The company is considering a reverse stock split, pending shareholder approval.